Y. Park

Patients and Methods: a Candidate Array Was Designed Based on the Breast Cancer Information Core Database For

B. Monk, R. Favis, P. Ghatage, 2022 .

Phase III double-blind placebo-controlled study of farnesyl transferase inhibitor R115777 in patients with refractory advanced colorectal cancer.

W. Scheithauer, J. Pérez-Ruixo, Y. Humblet, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Liposomal prostaglandin E1 (TLC C-53) in acute respiratory distress syndrome: a controlled, randomized, double-blind, multicenter clinical trial. TLC C-53 ARDS Study Group.

L. Nelson, E. Fletcher, E. Abraham, 1999, Critical care medicine.

Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancer.

G. Batist, J. Gutheil, M. Nair, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

753OFINAL OVERALL SURVIVAL (OS) ANALYSIS OF COU-AA-302, A RANDOMIZED PHASE 3 STUDY OF ABIRATERONE ACETATE (AA) IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) PATIENTS (PTS) WITHOUT PRIOR CHEMOTHERAPY.

F. Saad, K. Miller, C. Sternberg, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.